Adult Immunization in Office Practice Naveen Thacker, Niranjan Shendurnikar, Abhay K Shah, Tushar P Shah
INDEX
ABCDEFGHIJKLMNOPQRSTUVWYZ
Page numbers followed by b refer to box, f refer to figure, and t refer to table.
A
Abdala 168
Accidental needle stick injuries 82
Acellular pertussis vaccine 18
Acquired immunodeficiency syndrome 75, 121, 188
Acute flaccid paralysis 41
Acute hypersensitivity reaction 41
Acute respiratory distress syndrome 73
Adaptive system 16
Adenovirus vectored vaccines 172
Adult vaccination 63
center, set-up of 48f
Adverse events following immunization 39, 42t, 48
grades of 40t
surveillance system 39
types of 39t
Advisory Committee on Immunization Practices 23, 39, 62, 69, 85, 89, 113, 127, 139, 142, 144, 160
Aedes aegypti 122
Aedes albopictus 122
Alcoholism 88
Allergy 148
Aluminum hydroxide 19
American Diabetes Association 144
Anaphylactoid reaction 41
Anaphylaxis 41
Antibody 16, 168
Antigen 16
presenting cells 16, 189
Anti-pertussis toxin 67
Anti-rabies
vaccination 121
vaccine 117, 160
Antivaxxers 60
Anxiety 27, 41
Arthritis 176
ASHA workers 62
Asian flu 74
Asplenia 130, 142, 146
congenital 88
Association of Physicians of India 78, 92, 128, 150
Asthma 88, 144
Astrazeneca vaccine 167, 180
Autonomy 61
B
Bacillus Calmette-Guérin 17, 19, 31, 33, 41, 188
B-cells 16
Biomedical Waste Management Rules 28, 28t
Bleeding disorder 142, 148
Blood products, antibody-containing 146
Body mass index 21
Bone marrow transplant 142
Bordetella pertussis 190
Bronchial asthma 78
C
Cancer 78, 188
chemotherapy 145
Cansino vaccine 167, 171–173
Cardiomyopathies 88
Cell culture vaccines 118
Centers for Disease Control and Prevention 24, 59, 114, 123, 129, 150, 159, 176
Central Bureau of Health Intelligence 67
Cerebrospinal fluid leak 88
Cervical cancer 12, 105
Chemotherapy 142
Chickenpox 4, 9, 109, 112
infection 109
Chinese hamster ovary cells 168
Cholera 127, 158
public health impact of 130
vaccine 131, 160
Chronic obstructive pulmonary disease 12, 78, 88, 142, 144
Cirrhosis 88
Coadministered vaccine 21
Cold chain 30
components of 31
maintenance 30
Common cold 73
Complement deficiencies 88
Conjugate pneumococcal vaccine 87
Continuous temperature recording devices 37
Corbevax 168–170, 173
Coronavac 166, 180
Coronavirus disease 2019 (COVID-19) 9, 47, 151, 158, 165, 172, 174–178
infection 180
pandemic 3, 9, 22, 24, 45, 47, 50, 53, 56, 58, 61
spread 22
vaccination 22, 45, 59, 60, 61, 78, 155, 161, 165, 170, 172, 172b, 174–178, 184, 185
guideline 161
vaccine 45, 141, 169–171, 173–179, 181, 182, 184, 186
booster doses of 182, 183
composition 186
contraindications of 176
development of 165
side effects of 170
Covavax 173
Covaxin 166, 169, 170, 173, 174, 180, 181
Covishield 167, 169–171, 173, 176, 177, 181
Covovax 168
Cowpox 59
Cuba's abdala 168
Curevac vaccine 167, 171
Cytokines 16
Cytolytic molecules 16
D
Damage-associated molecular patterns 170
Danger signals 16
Death 41
Delta variants 179, 182
Dengue 123
fever 122
infections 122
vaccine 122–125, 139, 140
position of 126
Dengvaxia 123, 140
efficacy of 123
Deoxyribonucleic acid 16
vaccines 125, 166
Diabetes mellitus 12, 78, 88
Digital data loggers 37
Digital maximum-minimum thermometers 36, 37f
Diphtheria 9, 67, 68
and tetanus 18, 33, 35
pertussis, and tetanus 9, 33, 35, 60, 67, 138
and tetanus vaccine 67
E
Ebola virus 18, 165
Emergency use authorization 165, 169
Empathy 55
Emphysema 88
Encephalitis 73
Encephalopathy 41
Eosinophils 16
Equine rabies immunoglobulin 119
Escherichia coli 125, 192
F
Fainting 41
Febrile seizures 41
Fever 42, 176
enteric 9, 13
Filamentous hemagglutinin 70
Flu 73
vaccine 73, 78
Food and Drug Administration 76
Fresh frozen plasma 146
G
Gamalaya 167, 171, 173
Gastrointestinal system 194
Gender neutral vaccination 108
Geometric mean titers 17, 181
Geriatric Society of India 92
Gluteal muscle 25
Graft versus host disease 145
Granulomatous disease, chronic 88
Guillain-Barré syndrome 22, 78, 172, 173
H
H1N1 3, 74–76
H2N2 74
H3N2 73–76
Haemophilus influenzae B 16, 19, 33, 82, 127, 129, 145, 146
Healthcare professional 45, 53, 150
Heart
disease 78, 88
failure, congestive 88
Hemagglutinin 74
Hematopoietic stem cell transplantation 145, 192
Hemoglobinopathies 88
Hepatitis 33
A 4, 9, 13, 24, 101, 137, 140, 143, 145, 151
adult 4
vaccination 102, 103
vaccine 11, 35, 101–103, 160
virus infection 101, 102, 144
B 9, 11, 24, 27, 28, 137, 143, 145, 151, 152
chronic 86
immunoglobulin 84, 153
infection 4, 81, 82, 84
surface antigen 153
vaccination, current status of 84
vaccine 35, 81, 84, 140, 151, 153t, 189
virus 15, 19, 81, 83, 84, 144
C 27, 28, 81, 137
vaccine, role of 103
Herpes viruses 188
Herpes zoster 5, 13, 113, 114
vaccine, common adverse effects of 114
Hong Kong flu 74
Human cytomegalovirus disease 192
Human immune system 15
Human immunodeficiency virus 27, 28, 75, 88, 105, 112, 121, 142, 151, 188
infection 88
Human papillomavirus 7, 18, 19, 24, 40, 105, 106, 137, 145, 188
infection 9, 105
vaccination 107
vaccine 105–107, 139
bivalent 106
Hypertension 88
Hypotonic hyporesponsive episode 41, 42
I
Immune system 15
pathogenesis of 122
role of 122
Immunity 6
active 15
cell-mediated 16, 110, 143
cellular 16
herd 20, 21f
humoral 16
passive 15
sterile 6
vaccine-induced 178
Immunization 3, 7
adult 46, 57
general aspects of 1
Immunocompetent host 142
Immunoglobulin
A 194
G 67
intravenous 146
M 110
Immunologic memory 18
Immunosuppressive therapy 142
Inactivated influenza vaccine 78
composition of 75
high-dose 75
Inactivated Kolar strain 132
Inactivated polio vaccine 33, 60, 82, 145, 148, 151, 158
Inactivated vaccine 19, 173
platform 166t
Inactivated whole virion vaccines 166
Indian Academy of Pediatrics 4
Indian Association of Occupational Health 93, 150
Indian Council of Medical Research 124, 191
Indian Medical Association 93, 150
Indian Society of Nephrology 93
Infectious diseases 3
Influenza 9, 33, 73, 151
A virus 74, 75
antigenic subtypes of 74t
illness 75
infection 74
prevention of 75
vaccination, benefits of 152
vaccine 73, 76–79, 79t, 151
dosage schedule of 76
safety data of 78
virus
A 3, 73
B 73
C 73
importance of 73
Injectable polio vaccine 155
Injection site abscess 41, 42
Innate immune system 16
Innate T-cells 16
Integrated digital thermometer 36
Intensive care unit 178
Intussusception 41
Invasive pneumococcal disease 12, 87, 88b
Isothermic cold boxes 31, 36
J
J&J 167, 173, 180
Janssen 169, 180
coronavirus disease 2019
(COVID-19) vaccine 167
Japanese encephalitis 19, 127, 131, 132
vaccine 3, 132, 155, 158
K
Kidney disease 78
chronic 141, 144
L
Lactation 142
Light-sensitive vaccines 35
Live oral Ty21A typhoid vaccine 96
Live-attenuated vaccine 18, 75, 76, 125, 132, 146
Liver disease 78
chronic 88, 103, 142, 144
Lower respiratory tract infections 12
Lymphadenitis 41
M
Malaria Policy Advisory Committee 190
Malaria vaccine 190
Malignancies 142
Measles 151
mumps, and rubella 19, 24, 33, 40, 61, 107, 127, 140, 142, 145, 151
vaccine 110, 140, 151
rubella 60, 153
vaccine 158
Meningococcal conjugate vaccine 127, 129
Meningococcal disease 9, 129
prevention 154
Meningococcal meningitis 11
Meningococcal polysaccharide vaccine 130
Meningococcal vaccine 130, 152, 154, 159
recommendation of 130
Microarray patches 195
Micronutrient deficiency 21
Middle east respiratory syndrome coronavirus 165
Misconceptions 53
Moderna 167, 169, 171, 172, 180
Monocytes 16
mRNA vaccines 166, 173
Mucosa-associated lymphoid tissues 193
Mucosal vaccination 193
Multisystem inflammatory syndrome 177
Mumps 151
Mycobacterium tuberculosis 188
Myocarditis 73
Myositis 73
N
National Action Plan for Dog Mediated Rabies Elimination 121
National Immunization Program 10, 45, 52, 61, 87, 140
National Institute of Allergy and Infectious Diseases 125, 166
National Vaccine Advisory Committee of Centre for Disease Control 28
National Vector Borne Disease Control Program 132
Natural killer T-cells 16, 191
Needle stick injuries 85
Needle-free injector system 169
Neglected tropical diseases 116
Neisseria meningitidis 11, 129, 152, 188
Neuralgia, postherpetic 114
Neuraminidase 74
Neuritis, brachial 41
Neurotropic human varicella-zoster virus 109
Neutrophils 16
Nonsteroidal anti-inflammatory drugs 177
Northern hemisphere pattern 74, 77f
Novavax 168, 173, 180
O
Omicron variants 179, 182, 185
O-phthaldialdehyde 90
Oral immunization, limitations of 194
Oral polio vaccine 33, 60, 146, 160
bivalent 158
Oral typhoid vaccine 146
Osteitis 41
Osteomyelitis 41
P
Papillomatosis, respiratory 106
Paratyphoid vaccine 191
Passive immunization 119
Pathogen-associated molecular patterns 170
Pertussis 9, 67, 68, 151, 188
Pfizer 167, 169, 171, 172, 180
Phagocytic disorders 88
Plasmodium falciparum 190
Pneumococcal conjugate vaccine 88, 143, 145
Pneumococcal disease 9, 12
Pneumococcal infection 87
Pneumococcal pneumonia 5
Pneumococcal polysaccharide 148
vaccine 88
Pneumococcal vaccination 93
Pneumococcal vaccine 12, 87, 89, 92, 93
Pneumonia, community-acquired 90
Polio 151, 158
vaccine 160
Poliomyelitis, inactivated 107
Polysaccharide 18
conjugated 18
Postexposure prophylaxis 117, 119t
Posthematopoietic stem cell transplantation 145t
Pregnancy 142
Protein 18
subunit vaccines 166, 168, 173
Pseudomonas aeruginosa 96
Public health disease surveillance 8
Q
Quadrivalent vaccine 107
R
Rabies 9, 116, 151
exposure, categories of 117t
immunoglobulin 117
monoclonal antibody 117
passive immunization 119
prophylaxis 117
vaccination 121
vaccine 116, 152, 155, 160, 190, 191
Radiotherapy 142, 145
Randomized controlled trial 90
Recombinant viral vector vaccines 166
Renal disease, chronic 144
Research Society for Study of Diabetes in India 93
Respiratory syncytial virus 22
Reverse transcription polymerase chain reaction 185
Rheumatoid arthritis 175
Rituxan therapy 175
Rituximab 175
Rubella 9, 13, 151
syndrome, congenital 137
S
Saccharomyces cerevisiae 82
Salmonella
enterica serovar typhi 95
paratyphi 191
typhi 95, 154, 191
Seizures 41, 42
Sepsis 41
Severe acute respiratory syndrome coronavirus 2 4, 19, 175
virus 24, 165, 185
Sexually transmitted infection 105
Shigella
flexneri 192
sonnei 192
Shingles 9
Sickle cell disease 88
Sinopharm 166, 171, 174, 184
Sinovac 166, 171, 174
Solid organ transplant 142, 145
Southern hemisphere pattern 74, 77f
Spanish flu 74
Splenectomy 88, 142
Splenic dysfunction 88
Spodoptera frugiperda 76
Sputnik-V 167, 169–171, 173, 180
Staphylococcus aureus 192
Stem thermometer 36
Steroids 142
Streptococcus pneumococci 87
Streptococcus pneumoniae 12, 73, 87, 143, 188
Swine flu 74
Sympathy 55
Systemic inflammatory response syndrome 73
T
T-cells 16, 83, 122, 189, 191
activation 15
immunity 185
Temperature monitoring devices 36
Tetanus 9, 67, 68
diphtheria, and pertussis 67, 68, 151
vaccine 138, 151
maternal 10
neonatal 10
prophylaxis 71t
toxoid 24, 31, 35, 35, 138
Tetravalent vaccines 76, 193
Thrombocytopenia 41
heparin-induced 176
T-lymphocyte deficiency 88
Toxic shock syndrome 41
Travel medicine 7
Triplex vaccine 192
Trivalent influenza vaccine 76
Tuberculosis 188
Tumor necrosis factor-alpha 171
Typhoid 96, 151
conjugate vaccine 19, 96, 98, 151
fever 95, 99
polysaccharide vaccine 160
vaccination 96
vaccine 95–99, 154
U
Universal Human Pre-Exposure Immunization Against Rabies 12
Universal Immunization Programme 3, 154
V
Vaccination
route 21
schedule 21
Vaccine 35, 45, 157
administration 23
behavior, spectrum of 62, 63f
carrier 31
delivery
reduced pain of 195
system 194, 195
failure 20
general aspect of 1
hesitancy 56
determinants of 62
induced thrombotic thrombocytopenia 172, 173
platforms 166f
preventable diseases 9, 15, 39, 45, 67, 127f, 142, 150, 157
epidemiology of 9
protection, correlate of 20
storage 30
types of 19, 19t, 79
vial monitor 37, 37f
Varicella 4, 13, 109, 151
disease 112
infection 109, 110
vaccine 109, 110, 112, 113, 151
safety profile of 111
virus 6
zoster
immunoglobulin 113
virus 109, 140
Vaxchora 130
Vibrio cholerae 130, 196
Viral vector vaccines 125, 167, 173
pros and cons of 173
W
Whole cell pertussis vaccines 138
Whooping cough 9
World Health Organization 46, 56, 77, 81, 87, 96, 101, 116, 137, 150, 153, 154, 157, 179, 182
categories 117t
World Rabies Day 121
Wound management 71t, 117
Y
Yellow fever 18, 148, 158, 161
vaccination 158, 159
vaccine 159
Z
Zika virus 165
Zoster vaccines 5, 109, 114
types of 114
Zycov-D 168–170, 173
×
Chapter Notes

Save Clear